---
figid: PMC9073802__atm-10-07-413-f1
pmcid: PMC9073802
image_filename: atm-10-07-413-f1.jpg
figure_link: /pmc/articles/PMC9073802/figure/f1/
number: Figure 1
figure_title: ''
caption: 'Agomir-21 aggravates the symptoms and inflammatory response of TNBS-induced
  colitis, and antagomir-21 is effective in relieving colitis and inflammation. (A,B)
  DAI and weight change rate. ##, agomir-21 + TNBS group compared with agomir control
  + TNBS group, P<0.01; ###, P<0.01; *, agomir-21 + TNBS group compared with TNBS
  group, P<0.05; ***, P<0.001; $, antagomir-21 + TNBS group compared with antagomir
  control + TNBS group and TNBS group, P<0.05; $$$, P<0.001; ^, antagomir-21 + TNBS
  group compared with control group, P<0.05; ^^, P<0.01; ^^^, P<0.001; ns represents
  no significant difference; &&&, all TNBS groups except antagomir-21 + TNBS group
  compared with control group, P<0.001. (C,D) Serum IL-1β and TNF-α levels. ns represents
  no significant difference; *, P<0.05; **, P<0.01; ***, P<0.001; n=5. TNBS, 2,4,6-trinitrobenzenesulfonic
  acid; DAI, disease activity index; IL-1β, interleukin-1 beta; TNF-α, tumor necrosis
  factor alpha. Agomircon, agomir control; Antagomircon, antagomir control.'
article_title: miR-21 antagonist alleviates colitis and angiogenesis via the PTEN/PI3K/AKT
  pathway in colitis mice induced by TNBS.
citation: Xiaoran Xie, et al. Ann Transl Med. 2022 Apr;10(7):413.
year: '2022'

doi: 10.21037/atm-22-944
journal_title: Annals of Translational Medicine
journal_nlm_ta: Ann Transl Med
publisher_name: AME Publishing Company

keywords:
- Colitis mice
- TNBS
- miR-21
- PTEN/PI3K/AKT
- angiogenesis

---
